233 related articles for article (PubMed ID: 29911923)
61. Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy.
Singh N; Heggermont W; Fieuws S; Vanhaecke J; Van Cleemput J; De Geest B
J Heart Lung Transplant; 2015 Nov; 34(11):1376-84. PubMed ID: 26198441
[TBL] [Abstract][Full Text] [Related]
62. Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia.
Chen N; Feng L; Qu H; Lu K; Li P; Lv X; Wang X
Oncol Rep; 2018 Jun; 39(6):3064-3072. PubMed ID: 29658610
[TBL] [Abstract][Full Text] [Related]
63. LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
Kristensen L; Kristensen T; Abildgaard N; Royo C; Frederiksen M; Mourits-Andersen T; Campo E; Møller MB
Eur J Haematol; 2016 Aug; 97(2):175-82. PubMed ID: 26558352
[TBL] [Abstract][Full Text] [Related]
64. Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia.
Kminkova J; Mraz M; Zaprazna K; Navrkalova V; Tichy B; Plevova K; Malcikova J; Cerna K; Rausch T; Benes V; Brychtova Y; Doubek M; Mayer J; Pospisilova S
Carcinogenesis; 2014 May; 35(5):992-1002. PubMed ID: 24306027
[TBL] [Abstract][Full Text] [Related]
65. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
66. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
Van Damme M; Crompot E; Meuleman N; Mineur P; Dessars B; El Housni H; Bron D; Lagneaux L; Stamatopoulos B
Epigenetics; 2014 Oct; 9(10):1374-81. PubMed ID: 25437053
[TBL] [Abstract][Full Text] [Related]
67. Role of
Rampazzo E; Bojnik E; Trentin L; Bonaldi L; Del Bianco P; Frezzato F; Visentin A; Facco M; Semenzato G; De Rossi A
Haematologica; 2017 Jul; 102(7):e253-e256. PubMed ID: 28385779
[No Abstract] [Full Text] [Related]
68. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
[TBL] [Abstract][Full Text] [Related]
69. Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status.
Shea LK; Honjo K; Redden DT; Tabengwa E; Li R; Li FJ; Shakhmatov M; Chiorazzi N; Davis RS
Blood Cancer J; 2019 May; 9(6):47. PubMed ID: 31092813
[No Abstract] [Full Text] [Related]
70. The role of the genetic abnormalities, epigenetic and microRNA in the prognosis of chronic lymphocytic leukemia.
Tari K; Shamsi Z; Reza Ghafari H; Atashi A; Shahjahani M; Abroun S
Exp Oncol; 2018 Dec; 40(4):261-267. PubMed ID: 30593759
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
72. Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
Lech-Maranda E; Grzybowska-Izydorczyk O; Wyka K; Mlynarski W; Borowiec M; Antosik K; Cebula-Obrzut B; Makuch-Lasica H; Nowak G; Klimkiewicz-Wojciechowska G; Wawrzyniak E; Bilinski P; Robak T; Warzocha K
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):477-86. PubMed ID: 22945689
[TBL] [Abstract][Full Text] [Related]
73. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A
Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576
[TBL] [Abstract][Full Text] [Related]
74. [Expression of MiR-148b-3p in Lung Adenocarcinoma and Its Correlation with Prognosis].
Huang Z; Li S; Ma Y; Wu N; Yang Y
Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):306-311. PubMed ID: 31109440
[TBL] [Abstract][Full Text] [Related]
75. Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression.
Szurián K; Csala I; Piurkó V; Deák L; Matolcsy A; Reiniger L
Leuk Res; 2017 Jul; 58():39-42. PubMed ID: 28407516
[TBL] [Abstract][Full Text] [Related]
76. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
77. Plasma Hsa-miR-92a-3p in correlation with lipocalin-2 is associated with sepsis-induced coagulopathy.
Wang Y; Wang H; Zhang C; Zhang C; Yang H; Gao R; Tong Z
BMC Infect Dis; 2020 Feb; 20(1):155. PubMed ID: 32075600
[TBL] [Abstract][Full Text] [Related]
78. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
Yang H; Wei YN; Zhou J; Hao TT; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
[TBL] [Abstract][Full Text] [Related]
79. Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.
Visco C; Falisi E; Young KH; Pascarella M; Perbellini O; Carli G; Novella E; Rossi D; Giaretta I; Cavallini C; Scupoli MT; De Rossi A; D'Amore ES; Rassu M; Gaidano G; Pizzolo G; Ambrosetti A; Rodeghiero F
Oncotarget; 2015 Jul; 6(21):18653-63. PubMed ID: 26087198
[TBL] [Abstract][Full Text] [Related]
80. Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia.
Aguilar-Hernandez MM; Rincon Camacho JC; Galicia Garcia G
Curr Oncol Rep; 2021 Apr; 23(6):66. PubMed ID: 33855607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
